Novel biomarkers for pulmonary hypertension in children with ventricular septal defect
Conclusion Galectin-3 and H-FABP are promising cardiac biomarker for prediction and risk stratification of PH in children with VSD.
Source: Egyptian Pediatric Association Gazette - Category: Pediatrics Source Type: research
More News: Cardiology | Children | Heart | Heart Disease | Hole in the Heart | Hypertension | Pediatrics | Pulmonary Hypertension | Research | Study | Ventricular Septal Defect